Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
NRX Pharmaceuticals, Inc. execution reads as mixed on proprietary earnings and initiative evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 0d ago
NRXPW's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on NRXPW.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for NRX Pharmaceuticals, Inc. (NRXPW) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
NRXPW's AI investment thesis
Upgrade to Premium for NRXPW's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$0.00
Market cap
$112,568.00
Profitable
No
Revenue $1.23M
Net income
$-28.62M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for NRX Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow NRX Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.